Literature DB >> 8839732

15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma.

G Minniti1, M L Jaffrain-Rea, P Lunardi, A Gulino, G Tamburrano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8839732     DOI： 10.1007/bf01957160

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  Should dopamine agonist treatment for prolactinomas be life-long?

Authors:  G Faglia
Journal:  Clin Endocrinol (Oxf)       Date:  1991-03       Impact factor: 3.478

2.  Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.

Authors:  S Tsagarakis; A Grossman; P N Plowman; A E Jones; R Touzel; L H Rees; J A Wass; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1991-05       Impact factor: 3.478

3.  A decade of pituitary microsurgery. The Herbert Olivecrona lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

4.  [Prolactin-secreting pituitary adenomas in children and adolescents. Study of a series of 8 cases].

Authors:  R Barrio; M Roger; J L Chaussain; J C Job
Journal:  Arch Fr Pediatr       Date:  1979 Sep-Oct

5.  Dopamine agonists and pituitary tumor shrinkage.

Authors:  J S Bevan; J Webster; C W Burke; M F Scanlon
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

6.  Transsphenoidal surgery for pituitary adenomas in children.

Authors:  E H Dyer; T Civit; A Visot; O Delalande; P Derome
Journal:  Neurosurgery       Date:  1994-02       Impact factor: 4.654

7.  Pituitary adenomas in childhood and adolescence.

Authors:  L A Kane; M C Leinung; B W Scheithauer; E J Bergstralh; E R Laws; R V Groover; K Kovacs; E Horvath; D Zimmerman
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958
  7 in total
  1 in total

1.  Primary sphenoid sinus neoplasms: a report of four cases with common clinical presentation treated with transsphenoidal surgery and adjuvant therapies.

Authors:  Felice Esposito; Daniel F Kelly; Harry V Vinters; Antonio A F DeSalles; Joel Sercarz; Alessandra A Gorgulhos
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.